HQ Function

Formerly served as the primary center for research and development, clinical operations, and corporate administration for the company's microbiome therapeutic programs.

Notable Features:

The facility likely housed advanced laboratory spaces for microbiome research, analytical chemistry, and process development, alongside typical corporate office amenities. Specific architectural highlights are not widely publicized for a company of its nature and lifespan.

Work Culture:

As a clinical-stage biotech, the work culture was likely characterized by a fast-paced, innovative, and science-driven environment. Teams would have been focused on research breakthroughs, clinical trial execution, and regulatory milestones. This is no longer applicable as operations have ceased.

HQ Significance:

The headquarters was significant as the nerve center for Kaleido's pioneering efforts in Microbiome Metabolic Therapies. It was where their scientific strategy was developed and executed before the company's bankruptcy.

Values Reflected in HQ: The headquarters would have aimed to reflect values such as scientific innovation, collaboration, and a commitment to patient health, common in the biopharmaceutical industry, before its operational wind-down.

Location:

Kaleido Biosciences was primarily U.S.-based, with its operations centered in Massachusetts. While its clinical trials might have involved sites or collaborations internationally, as is common in drug development, the company did not maintain a significant network of international offices. All global activities ceased with its bankruptcy and asset sale in 2022.

Street Address:

18 Crosby Drive

City:

Bedford

State/Province:

MA

Country:

USA